REGN
BUY Regeneron Pharmaceuticals, Inc. · US
—
—
Prices as of close 2026-07-28
High-quality biotech with durable earnings, large-cap liquidity, and multiple near-term readout catalysts.
Buy signals
- ▸Analyst confidence and catalyst-rich pipeline underpin current support.
Related Biotech picks
AI-generated research for educational purposes only — not investment advice. Prices are end-of-day.